These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2275224)

  • 21. Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.
    Renke M; Tylicki L; Rutkowski P; Knap N; Zietkiewicz M; Neuwelt A; Aleksandrowicz E; Łysiak-Szydłowska W; Woźniak M; Rutkowski B
    Acta Biochim Pol; 2010; 57(1):119-23. PubMed ID: 20309434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic nephropathy: renoprotective effects of pentoxifylline in the PREDIAN trial.
    He T; Cooper ME
    Nat Rev Nephrol; 2014 Oct; 10(10):547-8. PubMed ID: 25201141
    [No Abstract]   [Full Text] [Related]  

  • 23. [The treatment of diabetic nephropathy. The need for an early diagnosis].
    Teruel Briones JL
    Rev Clin Esp; 1999 Jan; 199(1):1-3. PubMed ID: 10089768
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study.
    Navarro JF; Mora C; Muros M; Maca M; Garca J
    Am J Kidney Dis; 2003 Aug; 42(2):264-70. PubMed ID: 12900807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin receptor blocker and N-acetyl cysteine for reduction of proteinuria in patients with type 2 diabetes mellitus.
    Rasi Hashemi S; Noshad H; Tabrizi A; Mobasseri M; Tayebi Khosroshahi H; Heydarnejad M; Khalaj MR; Aghamohammadzadeh N
    Iran J Kidney Dis; 2012 Jan; 6(1):39-43. PubMed ID: 22218118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of different calcium antagonists on proteinuria associated with diabetes mellitus.
    Demarie BK; Bakris GL
    Ann Intern Med; 1990 Dec; 113(12):987-8. PubMed ID: 2240922
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy.
    Navarro JF; Mora C
    Diabetes Care; 1999 Jun; 22(6):1006-8. PubMed ID: 10372263
    [No Abstract]   [Full Text] [Related]  

  • 28. A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria.
    Badri S; Dashti-Khavidaki S; Lessan-Pezeshki M; Abdollahi M
    J Pharm Pharm Sci; 2011; 14(1):128-37. PubMed ID: 21501559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients.
    Momeni A; Shahidi S; Seirafian S; Taheri S; Kheiri S
    Iran J Kidney Dis; 2010 Apr; 4(2):128-32. PubMed ID: 20404423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can Pentoxifylline be used as Adjunct Therapy to ACE Inhibitors and ARBs in Preserving Kidney Function?
    Carson C; Al-Makki A; Shepler B
    J Pharm Pharm Sci; 2016; 19(1):1-7. PubMed ID: 27096690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration.
    Navarro JF; Mora C; Rivero A; Gallego E; Chahin J; Macía M; Méndez ML; García J
    Am J Kidney Dis; 1999 Mar; 33(3):458-63. PubMed ID: 10070909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
    Ravid M; Savin H; Jutrin I; Bental T; Katz B; Lishner M
    Ann Intern Med; 1993 Apr; 118(8):577-81. PubMed ID: 8452322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why patients with diabetes, hypertension and/or proteinuria are not on angiotensin converting enzyme inhibitors.
    Gordian ME; Kelly J
    Alaska Med; 1998; 40(3):51-4. PubMed ID: 9785612
    [No Abstract]   [Full Text] [Related]  

  • 34. Pentoxifylline: Evidence strong enough for renoprotection?
    Lai TS; Chiang WC; Chen YM
    J Formos Med Assoc; 2016 Aug; 115(8):591-2. PubMed ID: 26817833
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
    Bakris GL; Weir MR; DeQuattro V; McMahon FG
    Kidney Int; 1998 Oct; 54(4):1283-9. PubMed ID: 9767545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrotic range proteinuria; does it predict lung involvement in patients with type 2 diabetes.
    Al-Azzawi OFN; Alobaidy MW; Saham MM
    Diabetes Metab Syndr; 2019; 13(1):622-625. PubMed ID: 30641778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of add-on pentoxifylline on proteinuria in membranous glomerulonephritis: a 6-month placebo-controlled trial.
    Badri S; Dashti-Khavidaki S; Ahmadi F; Mahdavi-Mazdeh M; Abbasi MR; Khalili H
    Clin Drug Investig; 2013 Mar; 33(3):215-22. PubMed ID: 23392759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Losartan in patients with type 2 diabetes and proteinuria: observations from the RENAAL Study.
    Shahinfar S; Dickson TZ; Ahmed T; Zhang Z; Ramjit D; Smith RD; Brenner BM;
    Kidney Int Suppl; 2002 Dec; (82):S64-7. PubMed ID: 12410858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
    Hay U; Ludvik B; Gisinger C; Schernthaner G
    Schweiz Med Wochenschr; 1988 Feb; 118(5):165-9. PubMed ID: 3278375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus.
    Valmadrid CT; Klein R; Moss SE; Klein BE
    Arch Intern Med; 2000 Apr; 160(8):1093-100. PubMed ID: 10789601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.